Provided by Tiger Trade Technology Pte. Ltd.

Lyell Immunopharma, Inc.

14.38
-0.1500-1.03%
Volume:31.19K
Turnover:447.76K
Market Cap:352.37M
PE:-1.22
High:14.71
Open:14.51
Low:14.15
Close:14.53
52wk High:45.00
52wk Low:10.76
Shares:24.50M
Float Shares:10.79M
Volume Ratio:0.38
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.8281
EPS(LYR):-16.0562
ROE:-93.28%
ROA:-34.18%
PB:1.51
PE(LYR):-0.90

Loading ...

Lyell Immunopharma presents Phase 1/2 safety, translational data for ronde-cel in relapsed/refractory large B-cell lymphoma at EHA 2026

Reuters
·
Jun 05

Analysts Conflicted on These Healthcare Names: Arvinas Holding Company (ARVN), Lyell Immunopharma (LYEL) and Relay Therapeutics (RLAY)

TIPRANKS
·
Jun 03

Lyell Immunopharma Price Target Maintained With a $45.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 03

Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026

GlobeNewswire
·
Jun 01

Lyell Immunopharma (LYEL) Receives a Buy from H.C. Wainwright

TIPRANKS
·
May 27

Lyell Immunopharma to present at H.C. Wainwright BioConnect investor conference

Reuters
·
May 12

Lyell Immunopharma Announces Participation in May Investor Conferences

GlobeNewswire
·
May 12

Lyell Immunopharma Price Target Maintained With a $44.00/Share by Needham

Dow Jones
·
May 07

Lyell Immunopharma Q1 revenue misses, adjusted net loss narrows

Reuters
·
May 07

Lyell Immunopharma Q1 EPS $(1.10) Beats $(2.19) Estimate, Sales $2.000K Miss $4.400K Estimate

Benzinga Earnings
·
May 07

BRIEF-Lyell Immunopharma Q1 Net Income USD -24.153 Million

Reuters
·
May 07

Lyell Immunopharma Q1 Revenue USD 2 Thousand VS. Ibes Estimate USD 4.4 Thousand

THOMSON REUTERS
·
May 07

Lyell Immunopharma Q1 Operating Income USD -44.261 Million

THOMSON REUTERS
·
May 07

Lyell Immunopharma Q1 Operating Expenses USD 44.263 Million

THOMSON REUTERS
·
May 07

Press Release: Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026

Dow Jones
·
May 07

Baird Initiates Lyell Immunopharma at Outperform With $49 Price Target

MT Newswires Live
·
May 01

Lyell Immunopharma announces 2026 annual shareholder meeting webcast

Reuters
·
Apr 25

Lyell Immunopharma Stock (LYEL) Slides Despite Praise from a Top Wall Street Analyst

TIPRANKS
·
Apr 10

Needham & Co Initiates Coverage on Lyell Immunopharma With Strong Buy Rating, $44 Price Target

MT Newswires Live
·
Apr 10

Lyell Immunopharma Initiated at Buy by Needham

Dow Jones
·
Apr 10